Summit backs Dreampath Diagnostics to digitise global pathology labs

Summit Partners has announced a growth investment in Dreampath Diagnostics, a France-based healthtech company transforming pathology lab workflows through digital traceability and automation. Used by over 500 labs across nearly 40 countries, Dreampath’s platform archives and retrieves tissue samples with precision — reducing archiving time by 83% and lowering error rates.

The funding will fuel global expansion and accelerate Dreampath’s mission to modernise a historically manual segment of healthcare. With pathology labs under mounting pressure to scale, digitisation is becoming essential.

Read how Dreampath is reshaping diagnostic infrastructure worldwide here.